title: Antibiotic Treatment of Hospitalized Patients with Pneumonia Complicated by Clostridium Difficile Infection.
abstract: Clostridium difficile infection (CDI) is one of the most common gastrointestinal complication after antimicrobial treatment. It is estimated that CDI after pneumonia treatment is connected with a higher mortality than other causes of hospitalization. The aim of the study was to assess the relationship between the kind of antibiotic used for pneumonia treatment and mortality from post-pneumonia CDI. We addressed the issue by examining retrospectively the records of 217 patients who met the diagnostic criteria of CDI. Ninety four of those patients (43.3 %) came down with CDI infection after pneumonia treatment. Fifty of the 94 patients went through severe or severe and complicated CDI. The distribution of antecedent antibiotic treatment of pneumonia in these 50 patients was as follows: ceftriaxone in 14 (28 %) cases, amoxicillin with clavulanate in 9 (18 %), ciprofloxacin in 8 (16.0 %), clarithromycin in 7 (14 %), and cefuroxime and imipenem in 6 (12 %) each. The findings revealed a borderline enhancement in the proportion of deaths due to CDI in the ceftriaxone group compared with the ciprofloxacin, cefuroxime, and imipenem groups. The corollary is that ceftriaxone should be shunned in pneumonia treatment. The study demonstrates an association between the use of a specific antibiotic for pneumonia treatment and post-pneumonia mortality in patients who developed CDI.
authors.affiliation: Department of Family Medicine with Internal and Metabolic Diseases Ward, Warsaw Medical University, 19/25 Stępinska Street, 00-739, Warsaw, Poland. kzycinska@poczta.fm.
authors.forename: K
authors.initials: K
authors.lastname: Zycinska
authors.affiliation: Department of Family Medicine with Internal and Metabolic Diseases Ward, Warsaw Medical University, 19/25 Stępinska Street, 00-739, Warsaw, Poland.
authors.forename: M
authors.initials: M
authors.lastname: Chmielewska
authors.affiliation: Department of Family Medicine with Internal and Metabolic Diseases Ward, Warsaw Medical University, 19/25 Stępinska Street, 00-739, Warsaw, Poland.
authors.forename: B
authors.initials: B
authors.lastname: Lenartowicz
authors.affiliation: Department of Family Medicine with Internal and Metabolic Diseases Ward, Warsaw Medical University, 19/25 Stępinska Street, 00-739, Warsaw, Poland.
authors.forename: M
authors.initials: M
authors.lastname: Hadzik-Blaszczyk
authors.affiliation: Department of Family Medicine with Internal and Metabolic Diseases Ward, Warsaw Medical University, 19/25 Stępinska Street, 00-739, Warsaw, Poland.
authors.forename: M
authors.initials: M
authors.lastname: Cieplak
authors.affiliation: Department of Family Medicine with Internal and Metabolic Diseases Ward, Warsaw Medical University, 19/25 Stępinska Street, 00-739, Warsaw, Poland.
authors.forename: Z
authors.initials: Z
authors.lastname: Kur
authors.affiliation: Department of Family Medicine with Internal and Metabolic Diseases Ward, Warsaw Medical University, 19/25 Stępinska Street, 00-739, Warsaw, Poland.
authors.forename: R
authors.initials: R
authors.lastname: Krupa
authors.affiliation: Department of Family Medicine with Internal and Metabolic Diseases Ward, Warsaw Medical University, 19/25 Stępinska Street, 00-739, Warsaw, Poland.
authors.forename: K A
authors.initials: KA
authors.lastname: Wardyn
keywords: Antibiotics; Antimicrobial treatment; Clostridium difficile infection; Diarrhea; Gastrointestinal complications; Pneumonia